MPM Oncology Impact Management as of Dec. 31, 2019
Portfolio Holdings for MPM Oncology Impact Management
MPM Oncology Impact Management holds 12 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harpoon Therapeutics | 20.4 | $58M | 3.9M | 14.79 | |
| Epizyme | 20.3 | $57M | 2.3M | 24.60 | |
| Tcr2 Therapeutics Inc cs | 17.1 | $48M | 3.4M | 14.28 | |
| G1 Therapeutics | 13.3 | $38M | 1.4M | 26.43 | |
| ArQule | 7.7 | $22M | 1.1M | 19.96 | |
| Mei Pharma | 5.5 | $16M | 6.3M | 2.48 | |
| Deciphera Pharmaceuticals | 4.8 | $13M | 216k | 62.24 | |
| Argenx Se (ARGX) | 4.1 | $12M | 72k | 160.52 | |
| Y Mabs Therapeutics (YMAB) | 3.7 | $11M | 337k | 31.25 | |
| Cytomx Therapeutics (CTMX) | 2.5 | $7.1M | 855k | 8.31 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $955k | 2.8M | 0.34 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.2 | $525k | 40k | 13.21 |
